3-hydroxybenzoic acid

We are 3-hydroxybenzoic acid CAS:99-06-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:3-hydroxybenzoic acid
CAS.NO:99-06-9
Synonyms:3-hydroxybenzoic acid
m-hydroxylbenzoic acid
3-hydroxy benzoic acid
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 346.1±25.0 °C at 760 mmHg
Melting Point 201 °C
Molecular Formula C7H6O3
Molecular Weight 138.121
Flash Point 177.3±19.7 °C
Vapour Pressure 0.0±0.8 mmHg at 25°C
Index of Refraction 1.616
 
Specification:
Appearance:White crystalline powder
Assay:≥98.5%
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Fomesafen(CAS:72178-02-0).

3-hydroxybenzoic acid


Related News: In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.106-40-1 The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.82985-35-1 ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy.4-Amino-3,5-dichlorobenzotrifluoride CAS:24279-39-8 From basic chemical raw materials to chemical preparations, complex chemical and physical processes are required. The production of chemical raw materials and intermediates concentrates the main synthetic procedures and technical links, which is the prerequisite and important guarantee for the development of the chemical pharmaceutical industry.Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL.

Related Products
Product Name
Dicyclohexylchlorophosphine View Details
3-Bromo-2-chloro-5-(trifluoromethyl)pyridine View Details
4-Methoxypyridine View Details
3-Chloro-2-methylaniline manufacturer Thymidine-5′-monophosphate disodium salt manufacturer Tripeptide-9 Citrulline manufacturer 4,4,5,5,5-Pentafluoro-1-pentanethiol manufacturer 5,6,7,8-Tetrahydronaphthalene-1-carboxylic acid manufacturer